AU2002247725A1 - Antagonists fpr alpha4beta7-integrin - Google Patents
Antagonists fpr alpha4beta7-integrinInfo
- Publication number
- AU2002247725A1 AU2002247725A1 AU2002247725A AU2002247725A AU2002247725A1 AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1 AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1
- Authority
- AU
- Australia
- Prior art keywords
- fpr
- integrin
- antagonists
- antagonists fpr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107707.6 | 2001-02-19 | ||
DE2001107707 DE10107707A1 (de) | 2001-02-19 | 2001-02-19 | Antagonisten für alpha¶4¶beta¶7¶-Integrin |
PCT/EP2002/001745 WO2002066500A2 (fr) | 2001-02-19 | 2002-02-19 | ANTAGONISTES DE Α4β7-INTEGRINE |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002247725A1 true AU2002247725A1 (en) | 2002-09-04 |
Family
ID=7674566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002247725A Abandoned AU2002247725A1 (en) | 2001-02-19 | 2002-02-19 | Antagonists fpr alpha4beta7-integrin |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002247725A1 (fr) |
DE (1) | DE10107707A1 (fr) |
WO (1) | WO2002066500A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011095218A1 (fr) * | 2010-02-05 | 2011-08-11 | Polyphor Ag | Peptidomimétiques fixés au brin matrice ayant une activité modulatrice des cxcr7 |
US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
HRP20211911T1 (hr) | 2013-03-15 | 2022-03-18 | Protagonist Therapeutics, Inc. | Analozi hepcidina i njihova uporaba |
US20140294902A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide antagonists |
PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
BR112017006826A2 (pt) | 2014-10-01 | 2017-12-12 | Protagonist Therapeutics Inc | novos monômeros e dímeros peptídicos a4ss7 antagonistas |
WO2016054445A1 (fr) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Nouveaux peptides monomères et dimères cycliques possédant une activité antagoniste de l'intégrine |
US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
US11046695B2 (en) * | 2015-11-11 | 2021-06-29 | Zealand Pharma A/S | Fragment synthesis of substituted cyclic peptides |
CA3009834A1 (fr) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues de mimetiques d'hepcidine a demi-vie in vivo amelioree |
CN115925790A (zh) | 2016-03-23 | 2023-04-07 | 领导医疗有限公司 | 用于合成α4β7肽拮抗剂的方法 |
DK3538542T3 (da) | 2016-11-11 | 2021-10-11 | Zealand Pharma As | Cykliske peptidmultimerer målrettet alfa-4beta-7-integrin |
WO2018205008A1 (fr) | 2017-05-10 | 2018-11-15 | Encycle Therapeutics, Inc. | PEPTIDES CYCLIQUES HOMODÉTIQUES CIBLANT L'INTÉGRINE α4β7 |
EP3681900A4 (fr) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | Peptides d'agoniste opioïde et leurs utilisations |
US11753443B2 (en) | 2018-02-08 | 2023-09-12 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
CN116082455A (zh) | 2019-07-10 | 2023-05-09 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途 |
EP4090670A1 (fr) | 2020-01-15 | 2022-11-23 | Janssen Biotech, Inc. | Inhibiteurs peptidiques du récepteur de l'interleukine-23 et leur utilisation pour traiter des maladies inflammatoires |
CN115279782A (zh) | 2020-01-15 | 2022-11-01 | 詹森生物科技公司 | 白介素-23受体的肽抑制剂及其用于治疗炎性疾病的用途 |
KR20230110570A (ko) | 2020-11-20 | 2023-07-24 | 얀센 파마슈티카 엔.브이. | 인터류킨-23 수용체의 펩티드 억제제의 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
-
2001
- 2001-02-19 DE DE2001107707 patent/DE10107707A1/de not_active Withdrawn
-
2002
- 2002-02-19 WO PCT/EP2002/001745 patent/WO2002066500A2/fr not_active Application Discontinuation
- 2002-02-19 AU AU2002247725A patent/AU2002247725A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE10107707A1 (de) | 2002-08-29 |
WO2002066500A2 (fr) | 2002-08-29 |
WO2002066500A3 (fr) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002341834A1 (en) | Antagonists | |
AU2002360508A1 (en) | Substituted hydroxyethylamines | |
AU2002313565A1 (en) | Putter-heads | |
AU2002247725A1 (en) | Antagonists fpr alpha4beta7-integrin | |
AU2002315122A1 (en) | Self-guyed structures | |
AU2002251024A1 (en) | Substituted fluoroalcoxyphenylsulfonylurea | |
AU2003236247A1 (en) | Bombesin antagonists | |
AU2002321215A1 (en) | Substituted 4-aminocyclohexanols | |
AU2002346030A1 (en) | Novel receptors | |
AU2002313943A1 (en) | Electromobile | |
WO2002077001A9 (fr) | Nouveaux recepteurs | |
AU2002226571A1 (en) | Biligands | |
AU2001100406A4 (en) | DriverSMS | |
AU2002360933A1 (en) | Antagonists for alpha4-integrins | |
AU2002257925A1 (en) | Numberplates | |
AU2001100522A4 (en) | e-Trans | |
AU2002100746A4 (en) | Adrail | |
AU2001100214A4 (en) | Dolly-trolley | |
AU2001100532A4 (en) | FonePark | |
AU2001100338A4 (en) | Sunglove | |
AUPR910401A0 (en) | Athesive additives | |
AU2002363642A1 (en) | Nk1 antagonists | |
AU2002345578A1 (en) | Construction | |
AU2002311774A1 (en) | Novel receptors | |
AU2002358003A1 (en) | Substituted acylaminophenyluracils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |